|
Volumn 157, Issue 10, 2000, Pages 1686-1689
|
Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: Initial results from the depression in Alzheimer's disease study
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
SERTRALINE;
AGED;
ALZHEIMER DISEASE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DETERIORATION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
GERONTOPSYCHIATRY;
HUMAN;
MALE;
MENTAL HEALTH;
OUTPATIENT;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
AGED;
ALZHEIMER DISEASE;
AMBULATORY CARE;
COMORBIDITY;
DEPRESSIVE DISORDER;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
PLACEBOS;
PSYCHIATRIC STATUS RATING SCALES;
SEROTONIN UPTAKE INHIBITORS;
SERTRALINE;
TREATMENT OUTCOME;
|
EID: 0033797633
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.157.10.1686 Document Type: Article |
Times cited : (194)
|
References (13)
|